How To Use CPT Code 86367

CPT 86367 describes the process of counting the total number of CD34, or stem cells, in a patient’s blood specimen. This article will cover the description, procedure, qualifying circumstances, appropriate usage, documentation requirements, billing guidelines, historical information, similar codes and billing examples.

1. What is CPT Code 86367?

CPT 86367 can be used to describe the laboratory test performed to count the total number of CD34, or stem cells, in a patient’s blood specimen. This test is typically ordered by clinicians for research purposes or for clinical bone marrow transplantation. The test involves using an immunomagnetic or immunofluorescent method to identify and quantify the hematopoietic progenitor stem cells in the patient’s blood sample.

2. Official Description

The official description of CPT code 86367 is: ‘Stem cells (i.e., CD34), total count.’

3. Procedure

1. The lab analyst performs the technical steps to test the patient’s blood sample for the presence of CD34, or stem cells.
2. The analyst may use an immunomagnetic or immunofluorescent method to isolate and quantify the hematopoietic progenitor stem cells.
3. The test may involve various steps, such as using antibodies coated with paramagnetic beads to bind and trap the CD34 antigen.
4. The analyst then counts and records the total number of CD34, or stem cells, present in the patient’s blood specimen.

4. Qualifying circumstances

CPT 86367 is typically ordered by clinicians for research purposes or for clinical bone marrow transplantation. It is not limited to testing for specific conditions. The test helps quantify and purify the hematopoietic progenitor stem cells in the patient’s blood sample. CD34 is also found in the alveolar soft part of a sarcoma.

5. When to use CPT code 86367

CPT code 86367 should be used when a clinician orders a laboratory test to count the total number of CD34, or stem cells, in a patient’s blood specimen. It is important to note that this code is not limited to testing for specific conditions and can be used for research purposes or for clinical bone marrow transplantation.

6. Documentation requirements

To support a claim for CPT 86367, the documentation should include:

• Reason for ordering the test
• Details of the immunomagnetic or immunofluorescent method used
• Date of the test
• Results of the test, including the total count of CD34, or stem cells
• Signature of the lab analyst performing the test

7. Billing guidelines

When billing for CPT 86367, ensure that the test is performed by a qualified lab analyst using the appropriate method to count the total number of CD34, or stem cells. There are no specific guidelines regarding reporting CPT 86367 with other codes. However, it is important to follow any payer-specific guidelines and provide accurate documentation to support the claim.

8. Historical information

CPT 86367 was added to the Current Procedural Terminology system on January 1, 2006. There have been no updates to the code since its addition.

9. Examples

1. A clinician orders CPT 86367 to count the total number of CD34, or stem cells, in a patient’s blood specimen for research purposes.
2. A patient undergoes a clinical bone marrow transplantation, and CPT 86367 is used to quantify and purify the hematopoietic progenitor stem cells in their blood sample.
3. A researcher requests CPT 86367 to count the total number of CD34, or stem cells, in a patient’s blood specimen for a study on hematopoietic cell development.
4. A clinician orders CPT 86367 to assess the effectiveness of a new treatment in increasing the number of CD34, or stem cells, in a patient’s blood sample.
5. A patient with a suspected alveolar soft part sarcoma undergoes CPT 86367 to detect the presence of CD34 in their blood specimen.
6. A clinician orders CPT 86367 to monitor the levels of CD34, or stem cells, in a patient’s blood sample during the course of their treatment.
7. A researcher uses CPT 86367 to compare the levels of CD34, or stem cells, in different patient populations for a study on hematopoietic disorders.
8. A clinician orders CPT 86367 to assess the impact of a specific medication on the number of CD34, or stem cells, in a patient’s blood sample.
9. A patient with a history of bone marrow transplantation undergoes CPT 86367 to monitor the long-term levels of CD34, or stem cells, in their blood sample.
10. A researcher requests CPT 86367 to quantify the hematopoietic progenitor stem cells in a patient’s blood sample for a study on stem cell therapies.